Related Experiment Video
Updated: May 12, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.0K
Longitudinal Assessment of Parkinson's Motor Symptoms and Dopaminergic Dysfunction Patterns Using DaTSCAN
Amir Hossein Najmi1, Armin Ariaei2,3, Mahboobeh Khezri4
1School of Medicine, North Khorasan University of Medical Sciences, North Khorasan, Iran.
Clinical Parkinsonism & Related Disorders
|May 7, 2025
Summary
Dopamine transporter scans (DaTSCAN) show lower uptake in Parkinson's disease (PD) patients with dyskinesia and correlate with motor severity. DaTSCAN offers insights beyond diagnosis, particularly for postural instability and gait disturbance.
Area of Science:
- Neurology
- Radiology
- Neuroimaging
Background:
- Parkinson's disease (PD) staging and severity impact treatment decisions.
- Dopamine transporter scan (DaTSCAN) is effective for PD diagnosis, but its predictive role for motor function and symptom progression is debated.
Purpose of the Study:
- To assess the relationship between motor symptom patterns in Parkinson's disease and DaTSCAN findings.
- To explore DaTSCAN's utility in predicting motor dysfunction and disease severity.
Main Methods:
- 196 PD patients were analyzed, categorized by tremor, postural instability/gait difficulty (PIGD), and dyskinesia.
- Multivariate and logistic regression models examined associations between two-year motor symptom scores and DaTSCAN patterns.
Main Results:
- Lower DaTSCAN uptake was observed in patients with dyskinesia, especially in the right caudate and left putamen.
- DaTSCAN values strongly correlated with overall PD severity and Activities of Daily Living (ADL) scores.
- DaTSCAN measures negatively correlated with motor scores (MDS-UPDRS III, II, PIGD) but did not predict tremor-dominant scores.
Conclusions:
- DaTSCAN provides valuable information on PD disease severity and motor dysfunction, particularly postural instability and gait disturbance.
- Findings suggest DaTSCAN's utility extends beyond diagnosis to assessing specific motor deficits in Parkinson's disease.
Related Concept Videos
Parkinson's Disease: Treatment
154
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
154
Parkinson's Disease: Overview
319
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
319

